Nanox Imaging Ltd. (NASDAQ: NNOX), a medical imaging technology company, announced that its Nanox.ARC X digital tomosynthesis system has been named one of TIME's Best Inventions of 2026. The U.S. Food and Drug Administration-cleared system captures X-ray images from multiple angles, generating up to 200 coronal images per scan to produce three-dimensional views of the body at up to 80% less radiation than computed tomography (CT) for equivalent body parts. This recognition matters because it underscores a growing demand for imaging solutions that are both safer for patients and more practical for healthcare providers.
Designed with a smaller footprint than conventional CT systems, Nanox.ARC X operates using a standard 110-volt power outlet and features simplified installation, operator workflows and remote upgrade capabilities. These design choices could make advanced 3D imaging more accessible in a wider range of clinical settings, from outpatient clinics to remote locations, where space and power constraints often limit the adoption of traditional CT scanners. The company plans to showcase the system at the RSNA 2026 Annual Meeting in Chicago, where it will likely draw interest from radiologists, hospital administrators and investors.
Nanox previously received a special mention on TIME's Best Inventions of 2024 list for its artificial intelligence imaging solutions. The latest honor reinforces the company's position at the intersection of hardware innovation and AI-driven diagnostics. As healthcare systems worldwide grapple with rising costs and the need for earlier disease detection, technologies that lower radiation exposure and improve workflow efficiency could see accelerated adoption. For investors, the TIME recognition may serve as a catalyst for increased visibility and credibility, particularly as Nanox continues to build out its integrated imaging ecosystem.
Nanox (NASDAQ: NNOX) is focused on driving the world's transition to preventive health care by delivering an integrated, end-to-end medical imaging and healthcare services platform. The company combines affordable imaging hardware, advanced AI-based solutions, cloud-based software, access to remote radiology, health IT solutions, and a marketplace to enable earlier detection, improved clinical efficiency, and broader access to care. Its ecosystem includes Nanox.ARC, a cost-effective, 3D multi-source digital tomosynthesis imaging system designed for ease of use and scalability; Nanox.AI, a suite of AI-based algorithms that augment the interpretation of routine CT imaging to identify early signs often associated with chronic disease; Nanox.CLOUD, a cloud-based platform for secure data management, storage, and advanced imaging analytics; Nanox.MARKETPLACE and USARAD Holdings, which provide access to remote radiology and cardiology experts and comprehensive teleradiology services; and Nanox Health IT, which combines deep healthcare IT expertise with leading technology partners to deliver RIS, PACS, AI, dictation, and secure infrastructure solutions that streamline workflows and support safer, more efficient care delivery. By integrating imaging technology, AI, cloud infrastructure, clinical expertise, a marketplace, and health information technology, Nanox seeks to lower barriers to adoption, improve utilization, and advance preventive care worldwide.
To view the full press release, visit https://ibn.fm/wY1Fn. The latest news and updates relating to NNOX are available in the company's newsroom at http://ibn.fm/NNOX.
MissionIR, a specialized communications platform with a focus on assisting IR firms with syndicated content, is one of 75+ brands within the Dynamic Brand Portfolio @ IBN that delivers access to a vast network of wire solutions via InvestorWire, article and editorial syndication to 5,000+ outlets, enhanced press release enhancement, social media distribution via IBN, and a full array of tailored corporate communications solutions. For more information, please visit www.MissionIR.com. Please see full terms of use and disclaimers on the MissionIR website applicable to all content provided by MIR, wherever published or re-published: https://www.MissionIR.com/Disclaimer.
